panaxadiol has been researched along with catechin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, GJ; Rodriguez, M; Wang, CZ; Yuan, CS | 1 |
| Calway, T; Du, GJ; Du, W; He, TC; Qi, LW; Wang, CZ; Yuan, CS; Zhang, ZY | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
3 other study(ies) available for panaxadiol and catechin
| Article | Year |
|---|---|
Letter to the editor: Panaxadiol's anticancer activity is enhanced by epicatechin.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Camellia sinensis; Catechin; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Dose-Response Relationship, Drug; Drug Synergism; Ginsenosides; Humans; Magnoliopsida; Panax; Phytotherapy; Plant Extracts; Vitis | 2010 |
The synergistic apoptotic interaction of panaxadiol and epigallocatechin gallate in human colorectal cancer cells.
Topics: Annexin A5; Apoptosis; Catechin; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Drug Synergism; Ginsenosides; Humans; Molecular Docking Simulation | 2013 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |